Evaluating the Role and Policy Implications of Using External Evidence in Survival Extrapolations: A Case Study of Axicabtagene Ciloleucel Therapy for Second-Line DLBCL.
| Published in: | PharmacoEconomics Vol. 43; no. 11; pp. 1293 - 1308 |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Journal Article |
| Published: |
Springer Nature
Nov2025
|
| Online Access: | View this record in EBSCOhost |